PCRX logo

Pacira BioSciences, Inc. (PCRX)

Profile

Full Name

Pacira BioSciences, Inc.

Ticker

NASDAQ: PCRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

February 3, 2011

Indexes

Not included

Website

https://www.pacira.com

Employees

788

Key Details

Price

$27.12(+0.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$700.97M(+3.85% YoY)

Annual EPS

-$2.15(-341.57% YoY)

PE ratio

-

Next earnings date

Nov 5, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $27.12
    PCRX price is $27.12

    30-Day Relative Volume

    0.80
    PCRX 30-day relative volume is 0.80

    Price Performance

    Price Most recent change

    +0.33%
    PCRX price was up +0.33% on Sep 12, 2025

    Price YTD change

    +43.95%
    PCRX price is up +43.95% since January 1st

    Price 1-year change

    +113.04%
    PCRX price is up +113.04% year-on-year

    Price 3-year change

    -51.67%
    PCRX price is down -51.67% over the past 3 years

    Price Range

    Price All-time high

    $121.95
    PCRX price is currently -77.76% below its historical high of $121.95

    Price 3-year low

    $11.16
    PCRX price is currently +143.01% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.22B
    PCRX market capitalization is $1.22 billion

    Market cap 3-year change

    -52.62%
    PCRX market capitalization is down -52.62% over the past 3 years

    Market cap All-time high

    $4.32B
    PCRX market capitalization is currently -71.80% below its historical high of $4.32 billion

    Market cap sector rank

    74.85%
    PCRX market capitalization is higher than 74.85% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.59%
    PCRX shares outstanding is down -2.59% year-on-year

    Shares Outstanding 3-Year Change

    -1.95%
    PCRX shares outstanding is down -1.95% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.27
    PCRX beta is 0.27

    200-day SMA

    $23.73
    PCRX price is currently +14.27% above its 200-day simple moving average

    50-day SMA

    $24.24
    PCRX price is currently +11.88% above its 50-day simple moving average

    RSI

    64.40
    PCRX 14-day relative strength index is 64.40

    Volume

    0.80
    PCRX 30-day relative volume is 0.80

    ATR

    $0.93
    PCRX average true range is $0.93

    10-day Historical Volatility

    21.42%
    PCRX 10-day historical volatility is 21.42%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $700.97M
    PCRX annual revenue is $700.97 million

    Revenue Analysts estimate

    $737.83M
    PCRX annual revenue is currently -5.00% lower than the consensus analysts' forecast

    Revenue 1-year change

    +3.85%
    PCRX annual revenue is up +3.85% year-on-year

    Revenue Sector rank

    83.58%
    PCRX annual revenue is higher than 83.58% of companies in Healthcare sector

    EPS

    EPS

    -$2.15
    PCRX annual earnings per share is -$2.15

    EPS Analysts estimate

    $2.87
    PCRX annual earnings per share is currently -174.94% lower than the consensus analysts' forecast

    EPS 1-year change

    -341.57%
    PCRX annual earnings per share is down -341.57% year-on-year

    EPS Sector rank

    36.28%
    PCRX annual earnings per share is higher than 36.28% of companies in Healthcare sector

    Profit

    Gross profit

    $473.25M
    PCRX annual gross profit is $473.25 million

    Gross margin

    67.51%
    PCRX annual gross profit margin is 67.51%

    Operating profit

    $97.57M
    PCRX annual operating income is $97.57 million

    Operating margin

    -18.57%
    PCRX annual operating profit margin is -18.57%

    Net income

    -$99.56M
    PCRX annual net profit is -$99.56 million

    Net margin

    -14.20%
    PCRX annual net profit margin is -14.20%

    Expenses

    Total expenses

    $800.53M
    PCRX annual total expenses is $800.53 million

    Operating expenses

    $375.68M
    PCRX annual total operating expenses is $375.68 million

    Cost of goods sold

    $227.72M
    PCRX annual cost of goods sold is $227.72 million

    Selling, general & administrative expenses

    $0.00
    PCRX annual SGA is $0.00

    Depreciation and amortization

    $78.78M
    PCRX annual depreciation & amortization is $78.78 million

    Interest expense

    $0.00
    PCRX annual interest expense is $0.00

    Income tax

    $36.45M
    PCRX annual income tax is $36.45 million

    EBIT & EBITDA

    EBIT

    $97.57M
    PCRX annual earnings before interest & taxes is $97.57 million

    EBITDA

    $176.36M
    PCRX annual EBITDA is $176.36 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.55B
    PCRX annual total assets is $1.55 billion

    Non current assets

    $808.39M
    PCRX annual long term assets is $808.39 million

    Current assets

    $745.13M
    PCRX annual total current assets is $745.13 million

    Cash and cash equivalents

    $484.62M
    PCRX annual cash & cash equivalents is $484.62 million

    Accounts receivable

    $113.30M
    PCRX annual accounts receivable is $113.30 million

    Inventory

    $125.28M
    PCRX annual inventory is $125.28 million

    Liabilities

    Total liabilities

    $775.17M
    PCRX annual total liabilities is $775.17 million

    Long term liabilities

    $465.25M
    PCRX annual total long term liabilities is $465.25 million

    Current liabilities

    $309.92M
    PCRX annual total current liabilities is $309.92 million

    Accounts payable

    $19.13M
    PCRX annual accounts payable is $19.13 million

    Debt

    Total debt

    $638.85M
    PCRX annual total debt is $638.85 million

    Total debt 1-year change

    +9.01%
    PCRX annual total debt is up +9.01% year-on-year

    Long term debt

    $428.19M
    PCRX annual long term debt is $428.19 million

    Short term debt

    $210.66M
    PCRX annual short term debt is $210.66 million

    Equity & Capital

    Shareholders equity

    $778.35M
    PCRX annual stockholders equity is $778.35 million

    Book value

    $778.35M
    PCRX annual book value is $778.35 million

    Retained earnings

    -$206.36M
    PCRX annual retained earnings is -$206.36 million

    Working capital

    $435.21M
    PCRX annual working capital is $435.21 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $189.39M
    PCRX annual cash flow from operations is $189.39 million

    Cash from operations 1-year change

    +22.46%
    PCRX annual cash flow from operations is up +22.46% year-on-year

    Cash from investing

    -$83.28M
    PCRX annual cash flow from investing activities is -$83.28 million

    Cash from investing 1-year change

    -207.4%
    PCRX annual cash flow from investing activities is down -207.4% year-on-year

    Cash from financing

    $17.36M
    PCRX annual cash flow from financing activities is $17.36 million

    Cash from financing 1-year change

    +109.49%
    PCRX annual cash flow from financing activities is up +109.49% year-on-year

    CAPEX

    CAPEX

    $10.64M
    PCRX annual capital expenditures is $10.64 million

    CAPEX 1-year change

    -29.85%
    PCRX annual capital expenditures is down -29.85% year-on-year

    Free Cash Flow

    Free cash flow

    $178.75M
    PCRX annual free cash flow is $178.75 million

    Free cash flow 1-year change

    +28.15%
    PCRX annual free cash flow is up +28.15% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    67.51%
    PCRX annual gross profit margin is 67.51%

    Operating margin

    -18.57%
    PCRX annual operating profit margin is -18.57%

    Net margin

    -14.20%
    PCRX annual net profit margin is -14.20%

    ROA & ROE

    ROA

    -6.37%
    PCRX annual return on assets is -6.37%

    ROE

    -12.08%
    PCRX annual return on equity is -12.08%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PCRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PCRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.61
    PCRX price to book ratio is 1.61

    PB ratio Sector rank

    47.3%
    PCRX price to book ratio is higher than 47.3% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.73
    PCRX price to sales ratio is 1.73

    PS ratio Sector rank

    31.47%
    PCRX price to sales ratio is higher than 31.47% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.40B
    PCRX enterprise value is $1.40 billion

    Enterprise value Sector rank

    76.9%
    PCRX enterprise value is higher than 76.9% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1079.26
    PCRX EV/EBITDA is -1079.26

    EV/EBITDA Sector rank

    0.09%
    PCRX EV/EBITDA is higher than 0.09% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.40
    PCRX annual current ratio is 2.40

    Quick ratio

    2.00
    PCRX annual quick ratio is 2.00

    Leverage

    Debt to equity

    0.82
    PCRX annual debt to equity ratio is 0.82

    Interest coverage ratio

    -
    PCRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    6
    PCRX piotroski f-score is 6

    Altman Z-Score

    1.75
    PCRX altman z-score is 1.75

    Analyst ratings

    Recent major analysts updates

    May 9, 25 Needham
    Buy
    Apr 8, 25 Needham
    Buy
    Apr 8, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 Needham
    Buy
    Feb 28, 25 HC Wainwright & Co.
    Buy
    Feb 28, 25 Barclays
    Overweight
    Jan 30, 25 Truist Securities
    Hold
    Jan 14, 25 RBC Capital
    Sector Perform
    Jan 13, 25 Needham
    Buy
    Dec 17, 24 Needham
    Buy

    Institutional Ownership

    Screeners with PCRX included

    US stocks
    High Piotroski score stocks
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Pacira BioSciences, Inc.?
    • Does Pacira BioSciences, Inc. pay dividends?
    • What sector is Pacira BioSciences, Inc. in?
    • What industry is Pacira BioSciences, Inc. in?
    • What country is Pacira BioSciences, Inc. based in?
    • When did Pacira BioSciences, Inc. go public?
    • Is Pacira BioSciences, Inc. in the S&P 500?
    • Is Pacira BioSciences, Inc. in the NASDAQ 100?
    • Is Pacira BioSciences, Inc. in the Dow Jones?
    • When was Pacira BioSciences, Inc.'s last earnings report?
    • When does Pacira BioSciences, Inc. report earnings?

    What is the ticker symbol for Pacira BioSciences, Inc.?

    The ticker symbol for Pacira BioSciences, Inc. is NASDAQ:PCRX

    Does Pacira BioSciences, Inc. pay dividends?

    No, Pacira BioSciences, Inc. does not pay dividends

    What sector is Pacira BioSciences, Inc. in?

    Pacira BioSciences, Inc. is in the Healthcare sector

    What industry is Pacira BioSciences, Inc. in?

    Pacira BioSciences, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Pacira BioSciences, Inc. based in?

    Pacira BioSciences, Inc. is headquartered in United States

    When did Pacira BioSciences, Inc. go public?

    Pacira BioSciences, Inc.'s initial public offering (IPO) was on February 3, 2011

    Is Pacira BioSciences, Inc. in the S&P 500?

    No, Pacira BioSciences, Inc. is not included in the S&P 500 index

    Is Pacira BioSciences, Inc. in the NASDAQ 100?

    No, Pacira BioSciences, Inc. is not included in the NASDAQ 100 index

    Is Pacira BioSciences, Inc. in the Dow Jones?

    No, Pacira BioSciences, Inc. is not included in the Dow Jones index

    When was Pacira BioSciences, Inc.'s last earnings report?

    Pacira BioSciences, Inc.'s most recent earnings report was on August 5, 2025

    When does Pacira BioSciences, Inc. report earnings?

    The next expected earnings date for Pacira BioSciences, Inc. is November 5, 2025
    On this page